FDA, FTC Warn Seven Companies Selling Fraudulent Products to Treat COVID-19 Medical Dialogues Bureau11 March 2020 11:00 AM ISTThe FDA and FTC jointly issued warning letters to Vital Silver, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, GuruNanda,...
NY, feds sue 'Pharma Bro' Martin Shkreli for 'scheme' to keep drug price up MD bureau28 Jan 2020 2:21 PM ISTNEW YORK - State and federal authorities sued imprisoned entrepreneur Martin Shkreli on Monday over tactics that shielded a profitable drug from...
Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal Medical Dialogues Bureau26 Nov 2019 9:30 AM ISTIn September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
AbbVie says multiple parties vying for assets related to Allergan deal approval Medical Dialogues Bureau4 Nov 2019 9:00 AM ISTAbbVie Inc said it had notified the U.S. antitrust watchdog of its intention to divest its experimental inflammatory bowel disease therapy,...
Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny Farhat Nasim10 Jun 2019 9:30 AM ISTRoche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...
